Stockscreener 앱 받기
4.14
6.55%
-0.29
시간 외 거래:
4.36
0.22
+5.31%
전일 마감가:
$4.43
열려 있는:
$4.61
하루 거래량:
1.09M
Relative Volume:
0.79
시가총액:
$296.19M
수익:
$69.23M
순이익/손실:
$-33.10M
주가수익비율:
-3.5085
EPS:
-1.18
순현금흐름:
$-39.26M
1주 성능:
-8.00%
1개월 성능:
+9.23%
6개월 성능:
+500.00%
1년 성능:
+64.94%
1일 변동 폭
$4.13
$4.64
1주일 범위
$3.30
$4.815
52주 변동 폭
$0.52
$5.92
Neuronetics Inc Stock (STIM) Company Profile
명칭
Neuronetics Inc
전화
877-600-7555
주소
3222 PHOENIXVILLE PIKE, MALVERN, PA
STIM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
4.14 | 296.19M | 69.23M | -33.10M | -39.26M | -1.18 |
|
ABT
Abbott Laboratories
|
131.99 | 230.70B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.87 | 154.22B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.08 | 145.74B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.81 | 107.03B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.80 | 44.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-10-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2018-07-24 | 개시 | Canaccord Genuity | Buy |
모두보기
Neuronetics Inc 주식(STIM)의 최신 뉴스
Neuronetics Posts Strong Revenue Growth in Q1 2025 - MSN
Neuronetics, Inc. (NASDAQ:STIM) Released Earnings Last Week And Analysts Lifted Their Price Target To US$6.83 - Yahoo
Neuronetics, Inc. (NASDAQ:STIM) Just Reported And Analysts Have Been Lifting Their Price Targets - simplywall.st
Neuronetics, Inc. (NASDAQ:STIM) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Neuronetics Q1 2025 misses EPS, stock drops 22% - Investing.com Nigeria
Neuronetics Inc (STIM) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges - Yahoo Finance
Neuronetics Inc (STIM) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges By GuruFocus - Investing.com Canada
Neuronetics Reports Strong Q1 2025 Growth - TipRanks
Neuronetics: Q1 Earnings Snapshot - CTPost
Neuronetics Q1 2025 Earnings Call Transcript - MarketBeat
Neuronetics, Inc. Provides Earnings Guidance for the Second Quarter of 2025 - marketscreener.com
Neuronetics Q1 2025 slides: Combined entity targets profitability by Q3 amid 84% revenue growth - Investing.com Canada
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Neuronetics (STIM) Surpasses Q1 Revenue Expectations with $32M | - GuruFocus
Neuronetics Reports First Quarter 2025 Financial and Operating R - GuruFocus
Neuronetics Inc (STIM) Q1 2025 Earnings: Revenue Surpasses Estimates at $32.0M, EPS Misses at $(0.21) - GuruFocus
Neuronetics reports inducement grant - Medical Buyer
Neuronetics Announces CFO Retirement Amidst Q1 Growth - TipRanks
Neuronetics, Inc. SEC 10-Q Report - TradingView
Neuronetics Reports First Quarter 2025 Financial and Operating Results - The Manila Times
Renaissance Technologies LLC Has $255,000 Position in Neuronetics, Inc. (NASDAQ:STIM) - Defense World
JPMorgan Chase & Co. Increases Stock Holdings in Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5 - GuruFocus
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Neuronetics Expands Team with 4,500 Share RSU Package for Three New Strategic Hires - Stock Titan
Transcranial Magnetic Stimulator Market Generated - openPR.com
Neuronetics, Inc.'s (NASDAQ:STIM) 30% Jump Shows Its Popularity With Investors - simplywall.st
Neuronetics Announced as a Winner by 2022 Merit Awards for HealthCare in the Patient Care Category - IT Business Net
Geode Capital Management LLC Buys 8,466 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Taking the lead: Neuronetics Inc (STIM) - Sete News
Insider’s View: Deciphering Neuronetics Inc (STIM)’s Financial Health Through Ratios - DWinneX
Neuronetics Inc (STIM) stock on the rise: An overview - uspostnews.com
Why Neuronetics, Inc. (STIM) is Surging in 2025 - Insider Monkey
Transneural Therapeutics Appoints CNS Drug Development Expert, Mark A. Demitrack, MD, as Chief Research and Development Officer - The Malaysian Reserve
Neuronetics, Inc.'s (NASDAQ:STIM) market cap surged US$39m last week, individual investors who have a lot riding on the company were rewarded - simplywall.st
Neuronetics to Announce Q1 2025 Results and Host Live Conference Call on May 6 - MSN
Was there any good news for Neuronetics Inc (STIM) stock in the last session? - uspostnews.com
Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call | STIM Stock News - GuruFocus
Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call - The Manila Times
Medical Tech Leader Neuronetics Sets Q1 2025 Earnings Release: Key Details for Neurohealth Investors - Stock Titan
Neuronetics, Inc. (NASDAQ:STIM) Short Interest Update - Defense World
Neuronetics Reports 2024 Financial Results and Strategic Advances - MSN
Transcranial Magnetic Stimulator Market to Witness Remarkable - openPR.com
Neuronetics Announces Expanded Coverage for NeuroStar TMS to Treat Adolescent Depression - MSN
Even though Neuronetics (NASDAQ:STIM) has lost US$30m market cap in last 7 days, shareholders are still up 130% over 5 years - simplywall.st
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression - The Manila Times
Major Insurance Breakthrough: NeuroStar's Teen Depression Treatment Now Covered for 15 Million Lives - Stock Titan
Neuronetics Inc (STIM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.93%
자본화:
|
볼륨(24시간):